• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,864.47 -605.64
( -0.78%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,580.59 55.83
(0.53%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
159.91
470785.51
EPS(TTM)
Face Value()
Div & Yield %
12.27
1
0.82
 

Bhagawati Oxygen standalone net profit rises 2228.57% in the March 2026 quarter
May 30,2026
Net profit of Bhagawati Oxygen rose 2228.57% to Rs 3.26 crore in the quarter ended March 2026 as against Rs 0.14 crore during the previous quarter ended March 2025. Sales remain constant at Rs 0.01 crore in the quarter ended March 2026 and also during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 3.27 crore in the year ended March 2026 as against net loss of Rs 0.45 crore during the previous year ended March 2025. Sales declined 39.51% to Rs 0.49 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.010.01 0 0.490.81 -40
OPM %-4600.00-3700.00 --253.06-150.62 -
PBDT3.340.08 4075 3.39-0.47 LP
PBT3.330.07 4657 3.35-0.51 LP
NP3.260.14 2229 3.27-0.45 LP